Purchases and Sales Made in Q2 2022 in Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV) during Q2 2022. The information is specifically focused on institutions that hold shares of Elevation Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
233K+ 917.32% |
$294K - $918K
|
258K
$173K
|
|
|
Aug 10, 2022
Q2 2022
|
Kennedy Capital Management, Inc.
St Louis, MO |
BUY
|
- |
136K+ 968.37% |
$171K - $535K
|
150K
$100K
|
|
|
Aug 15, 2022
Q2 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
100K+ 176.99% |
$126K - $394K
|
157K
$105K
|
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
24.7K+ 6.57% |
$31.1K - $97.3K
|
401K
$269K
|
|
|
Aug 09, 2022
Q2 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
21.8KNew |
$27.5K - $85.9K
|
21.8K
$14.6K
|
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.33K+ 161.9% |
$4.19K - $13.1K
|
5.38K
$3.61K
|
|
|
Aug 15, 2022
Q2 2022
|
Caxton Corp
Princeton, NJ |
BUY
|
- |
14+ 0.02% |
$17.6 - $55.2
|
68.3K
$45.8K
|
|
|
Aug 15, 2022
Q2 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
3+ 0.0% |
$3.78 - $11.8
|
1.98M
$1.33M
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 7.69% |
$3.78 - $11.8
|
42
$28.1
|
|
|
Aug 15, 2022
Q2 2022
|
Bvf Inc
San Francisco, CA |
BUY
|
- |
2+ 0.0% |
$2.52 - $7.88
|
2.31M
$1.55M
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-60Closed |
$75.6 - $236
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-507- 1.33% |
$639 - $2K
|
37.7K
$25.3K
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6.22K- 98.19% |
$7.84K - $24.5K
|
115
$77.1
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6.22K- 98.19% |
$7.84K - $24.5K
|
115
$77.1
|
|
|
Aug 15, 2022
Q2 2022
|
Lynx1 Capital Management LP
San Juan, PR |
SELL
|
- |
-10KClosed |
$12.6K - $39.4K
|
0
$0
|
|
|
Jul 27, 2022
Q2 2022
|
Bailard, Inc.
|
SELL
|
- |
-23.5KClosed |
$29.6K - $92.6K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-102K- 10.91% |
$128K - $401K
|
831K
$556K
|
|
|
Aug 15, 2022
Q2 2022
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-497KClosed |
$626K - $1.96M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Ven Bio Partners LLC
San Francisco, CA |
SELL
|
- |
-742K- 28.44% |
$935K - $2.92M
|
1.87M
$1.25M
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-931K- 83.86% |
$1.17M - $3.67M
|
179K
$120K
|
|
|
Aug 15, 2022
Q2 2022
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-1.57MClosed |
$1.98M - $6.19M
|
0
$0
|